BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

827 related articles for article (PubMed ID: 18385900)

  • 1. Androgenic-anabolic steroids and the Olympic Games.
    Fitch KD
    Asian J Androl; 2008 May; 10(3):384-90. PubMed ID: 18385900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of androgenic anabolic steroids before and during the Olympic Games: less but has not died out].
    de Ronde W
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1820-4. PubMed ID: 18783159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays.
    Houtman CJ; Sterk SS; van de Heijning MP; Brouwer A; Stephany RW; van der Burg B; Sonneveld E
    Anal Chim Acta; 2009 Apr; 637(1-2):247-58. PubMed ID: 19286037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of androgenic anabolic steroids in urine.
    Hatton CK; Catlin DH
    Clin Lab Med; 1987 Sep; 7(3):655-68. PubMed ID: 3308301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen abuse in sports.
    Handelsman DJ; Heather A
    Asian J Androl; 2008 May; 10(3):403-15. PubMed ID: 18385902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aortic elastic properties in athletes using anabolic-androgenic steroids.
    Kasikcioglu E; Oflaz H; Arslan A; Topcu B; Kasikcioglu HA; Umman B; Bugra Z; Kayserilioglu A
    Int J Cardiol; 2007 Jan; 114(1):132-4. PubMed ID: 16364476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use and abuse of anabolic steroids in Olympic-caliber athletes.
    Bergman R; Leach RE
    Clin Orthop Relat Res; 1985 Sep; (198):169-72. PubMed ID: 4028547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies that athletes use to avoid detection of androgenic-anabolic steroid doping and sanctions.
    Alquraini H; Auchus RJ
    Mol Cell Endocrinol; 2018 Mar; 464():28-33. PubMed ID: 28130115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic anabolic agents: steroids and nonsteroidal selective androgen receptor modulators.
    Thevis M; Schänzer W
    Handb Exp Pharmacol; 2010; (195):99-126. PubMed ID: 20020362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. History of mass spectrometry at the Olympic Games.
    Hemmersbach P
    J Mass Spectrom; 2008 Jul; 43(7):839-53. PubMed ID: 18570181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of doping agents, particularly anabolic steroids, in sports and society.
    Sjöqvist F; Garle M; Rane A
    Lancet; 2008 May; 371(9627):1872-82. PubMed ID: 18514731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the detection of designer steroids in anti-doping.
    Abushareeda W; Fragkaki A; Vonaparti A; Angelis Y; Tsivou M; Saad K; Kraiem S; Lyris E; Alsayrafi M; Georgakopoulos C
    Bioanalysis; 2014 Mar; 6(6):881-96. PubMed ID: 24702116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anabolic steroids in sport.
    VanHelder WP; Kofman E; Tremblay MS
    Can J Sport Sci; 1991 Dec; 16(4):248-57. PubMed ID: 1663826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication use by athletes at the Athens 2004 Summer Olympic Games.
    Tsitsimpikou C; Tsiokanos A; Tsarouhas K; Schamasch P; Fitch KD; Valasiadis D; Jamurtas A
    Clin J Sport Med; 2009 Jan; 19(1):33-8. PubMed ID: 19124981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anabolic steroids in sport: biochemical, clinical and analytical perspectives.
    Kicman AT; Gower DB
    Ann Clin Biochem; 2003 Jul; 40(Pt 4):321-56. PubMed ID: 12880534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicine and science in the fight against doping in sport.
    Catlin DH; Fitch KD; Ljungqvist A
    J Intern Med; 2008 Aug; 264(2):99-114. PubMed ID: 18702750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of anabolic-androgenic steroids purity certified reference materials for anti-doping.
    Quan C; Su F; Wang H; Li H
    Steroids; 2011 Dec; 76(14):1527-34. PubMed ID: 21925194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sports-related issues and biochemistry of natural and synthetic anabolic substances.
    Parr MK; Flenker U; Schänzer W
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):45-57, viii. PubMed ID: 20122449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.
    Lane HA; Grace F; Smith JC; Morris K; Cockcroft J; Scanlon MF; Davies JS
    Eur J Clin Invest; 2006 Jul; 36(7):483-8. PubMed ID: 16796605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
    Geyer H; Schänzer W; Thevis M
    Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.